Cyclopeptide RA-V inhibits cell adhesion and invasion in both estrogen receptor positive and negative breast cancer cells via PI3K/AKT and NF-κB signaling pathways-Reference-Cited by-同舟云学术

Cyclopeptide RA-V inhibits cell adhesion and invasion in both estrogen receptor positive and negative breast cancer cells via PI3K/AKT and NF-κB signaling pathways

Published:2015-08 Issue:8 Volume:1853 Page:1827-1840
ISSN:0167-4889
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Author:

Leung Hoi-Wing,Wang Zhe,Yue Grace Gar-Lee,Zhao Si-Meng,Lee Julia Kin-Ming,Fung Kwok-Pui,Leung Ping-Chung,Lau Clara Bik-San,Tan Ning-Hua

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference43 articles.

1. Breast cancer metastasis: markers and models;Weigelt;Nat. Rev. Cancer,2005

2. Tumor metastasis: mechanistic insights and clinical challenges;Steeg;Nat. Med.,2006

3. Plants as a source of anti-cancer agents;Cragg;J. Ethnopharmacol.,2005

4. Bouvardin and deoxybouvardin, antitumor cyclic hexapeptides from Bouvardia ternifolia (Rubiaceae);Jolad;J. Am. Chem. Soc.,1977

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclopeptide RA-V from Rubia yunnanensis restores activity of Adagrasib against colorectal cancer by reducing the expression of Nrf2;Pharmacological Research;2024-08

2. Gypensapogenin H suppresses tumor growth and cell migration in triple-negative breast cancer by regulating PI3K/AKT/NF-κB/MMP-9 signaling pathway;Bioorganic Chemistry;2022-09

3. Diversity of cultivable endophytic fungi in two Rubia plants and their potential for production of anti‐tumour Rubiaceae‐type cyclopeptides;Letters in Applied Microbiology;2021-10-10

4. Decoupling tumor cell metastasis from growth by cellular pilot protein TNFAIP8;Oncogene;2021-10-04

5. Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy;Acta Pharmaceutica Sinica B;2021-10